Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M403407200 on June 2, 2004 Originally published In Press as doi:10.1074/jbc.M403407200 on May 27, 2004

J. Biol. Chem., Vol. 279, Issue 32, 33220-33227, August 6, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/32/33220    most recent
M403407200v2
M403407200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhai, L.
Right arrow Articles by Cumberledge, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhai, L.
Right arrow Articles by Cumberledge, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Drosophila Wnt-1 Undergoes a Hydrophobic Modification and Is Targeted to Lipid Rafts, a Process That Requires Porcupine*

Linda Zhai, Deepti Chaturvedi{ddagger}, and Susan Cumberledge§

From the Department of Biochemistry and Molecular Biology, University of Massachusetts, Amherst, Massachusetts 01003

Received for publication, March 26, 2004 , and in revised form, May 26, 2004.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Wnt signaling pathways regulate many developmental responses; however, little is known about how Wnt ligands function on a biochemical level. Recent studies have shown that Wnt-3a is palmitoylated before secretion. Here we report that Drosophila Wnt-1 (Wingless) also undergoes a lipid modification. Lipidation occurs in the endoplasmic reticulum and is dependent on Porcupine, a putative O-acyltransferase. After modification, DWnt-1 partitions as a membrane-anchored protein and is sorted into lipid raft detergent-insoluble microdomains. Lipidation, raft targeting, and secretion can be blocked by the addition of 2-bromopalmitate, a competitive inhibitor of O-acyltransferase activity. Based on these results we propose a model whereby lipidation targets Wnt-1 to secretory vesicles that deliver the ligand to specialized microdomains at the cell surface where it can be packaged for secretion.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Wnt ligands play key roles in many developmental pathways (1-3). To understand how Wnts regulate so many developmental activities, it is necessary to define the biochemical steps that constitute the actual signal transduction events. With this goal in mind, we are studying the synthesis and secretion of active Wnt-1 ligand in Drosophila melanogaster. The WNT genes encode a large family of secreted proteins; these ligands share a signature WNT motif (C-K-C-H-G-(LIVMT)-S-G-X-C), 22 conserved cysteines, many highly charged amino acid residues, and several potential glycosylation sites. Based on their amino acid sequences, Wnt proteins should be soluble, secreted glycoproteins; yet, Wnts do not exhibit the properties expected of soluble hydrophilic proteins. For example, we have examined Drosophila Wnt-1 expression in transgenic S2 cells and found that only about 20% of the secreted protein is present in soluble conditioned medium; the majority of the extracellular Wnt-1 is associated with the cell surface and extracellular matrix (4). Recent work by Nusse and co-workers (5) has shown that murine Wnt-3a is palmitoylated at a conserved cysteine residue (Cys-77). Their discovery suggests for the first time that lipid modifications may account for the unusual behavior of Wnt ligands. How palmitoylation affects Wnt-3a signaling and whether or not other Wnts are modified in a similar manner are questions now under investigation. Here, we provide evidence that Drosophila Wnt-1 is also lipid-modified. In addition, we investigate the functional significance of the lipid modification and the role of porcupine in Wnt-1 maturation and secretion.

Many types of proteins (including cytosolic, transmembrane, and secreted proteins) are known to undergo S-palmitoylation, the reversible addition of palmitate to a cysteine via a thioester bond (6). This posttranslational acylation is readily reversible and can regulate both protein localization and function. The addition of the palmitoyl moiety increases protein hydrophobicity and promotes membrane association (6). Palmitoylation also affects intracellular trafficking in that palmitoylated proteins are frequently targeted to specific intracellular organelles as well as to detergent-resistant microdomains (DRMs)1 located at the plasma membrane (7, 8). These DRMs, commonly referred to as lipid rafts, are rich in cholesterol and glycosphingolipids and so exist in a separate liquid-ordered phase within the plasma membrane (9). Raft DRMs often form signal transduction centers. The cellular machinery needed for signal transduction becomes organized as some proteins are targeted to rafts, whereas others are excluded. For example, cell surface receptors are sometimes localized to same membrane microdomains where their downstream intracellular partners are also concentrated (10).

Secreted proteins can also be palmitoylated. The mature form of Hedgehog, Hh-Np, contains two unusual lipid modifications (a C-terminal linked cholesterol moiety and an N-terminal palmitoyl adduct). These lipid modifications increase Hh-Np hydrophobicity, influence apical sorting of the ligand, and likely play a role in the partitioning of Hh-Np into raft DRMs (11-14). Skinny Hedgehog, a putative O-acyltransferase, is required for the palmitoylation of Drosophila Hh-Np (15). Clonal analysis studies (12) suggest that palmitoylation is essential for Hh signaling in the wing disc. In the absence of Skinny Hedgehog activity, Hh-Np is not palmitoylated, and Hedgehog signaling activity is greatly reduced.

Skinny Hedgehog belongs to a diverse family of membrane-bound O-acyltransferases (16). Many of these enzymes catalyze the transfer of fatty acids to hydroxyl groups on hydrophobic targets. The target substrates vary widely and include lipids (cholesterol acyltransferase), alginate (AlgI), and waxes (wax synthase). Skinny Hedgehog is somewhat unusual in that it is required for the synthesis of a thioester-linked fatty acid. The chemistry of S-palmitoylation and the palmitoyl acyltransferase enzymes have not been well studied. Some palmitoyl acyltransferases reside in the cytosol; others, like Skinny Hedgehog, are thought to function within the ER (6, 15). Curiously, the vertebrate Sonic Hedgehog protein, Shh-Np, contains an amide-linked palmitoyl group at the N-terminal Cys. Pepinsky et al. (11) have suggested that Shh-Np acylation occurs via a two-step mechanism, which is the initial synthesis of a thioester intermediate linking the palmitoyl group to the side chain of the terminal cysteine followed by an intramolecular rearrangement that transfers the palmitoyl group to the N-terminal nitrogen (11). The presence of the amide bond may be functionally significant because an amide bond is far more stable than a thioester linkage.

It is intriguing that porcupine also encodes a putative multipass transmembrane protein belonging to the membrane-bound O-acyltransferase superfamily (16, 17). porcupine is required for Wnt-1 activity, and porcupine homologs have been identified in Xenopus, mouse, human, and Caenorhabditis elegans (18-20). Genetic and immunocytochemical studies suggest that porcupine is required for the secretion of active Wnt-1 ligand. porcupine functions upstream and is required by Wnt-1 expressing cells. Wnt-1 is synthesized in porcupine- mutants; however, it accumulates within the expressing cells. All extracellular Wnt-1 staining is absent, suggesting that Wnt-1 secretion is blocked in the porcupine- mutant animals (16, 21). The Wnt-1 secretion defect can be bypassed by driving overexpression of Wnt-1. In this case, ectopic Wnt-1 secretion leads to ectopic signaling and death. Thus porcupine has an essential role in directing proper Wnt-1 secretion. Studies with transgenic S2 cells (18, 22) have shown that Porcupine and the N-terminal portion of Wnt-1 can be co-immunoprecipitated in the same complex, suggesting that Porcupine may interact directly with Wnt-1. Several questions should now be addressed. Does Porcupine mediate a posttranslational modification of Wnt-1? If so, what is the modification, and why is this modification necessary for normal Wnt-1 secretion?

Here, we report a series of experiments testing the hypothesis that porcupine is required for lipidation of Wnt-1. We present evidence that Wnt-1 is lipid-modified and that this modification converts Wnt-1 into a membrane-anchored protein that is partitioned into specialized lipid raft microdomains before secretion. Moreover, we show that Porcupine activity is required for both lipidation and the subsequent targeting of DWnt-1 to specialized raft DRMs at the cell surface.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Cell Culture, Protein Induction, and Western Blotting—Drosophila S2 cell lines were cultured as described (4). S2-DWnt-1 cells carry a wingless/wg cDNA transgene under the control of the inducible Hsp70 promoter; S2-DFz2 cells (provided by Roel Nusse) have a Dfrizzled/Dfz2 cDNA transgene under control of the inducible metallothionein promoter. DWnt-1 expression was induced by heat shocking S2-DWnt-1 cells for 1 h at 37 °C followed by a 2-h recovery period at 25 °C. DFz2 expression was induced by treating S2-DFz2 cells with 70 mM CuSO4 for 2 h.

10% SDS-PAGE and Western analysis was performed as described (4). Antibody dilutions used were: mouse {alpha}DWnt-1 (ATCC), 1:1000; mouse {alpha}PCNA (Novacastra Laboratories Ltd., Novus Biologicals), 1:500; rabbit {alpha}DFz2, 1:10,000; mouse {alpha}syntaxin 1A 1:1000 (Developmental Studies Hybridoma Bank), mouse {alpha}Rac1 1:1500 (BD Biosciences), and mouse {alpha}Hsp70 1:10,000 (Affinity Bioreagents Inc).

Butyl-Sepharose Chromatography—Cells were washed in PBS, resuspended in 2 x 106 cells/ml cold binding buffer (100 mM NaCl, 10 mM Tris-Cl, pH 8.0, 0.025% CHAPS), with 1x protease inhibitor mixture (4-(2-aminoethyl)benzenesulfonyl fluoride, pepstatin A, E-64, bestatin, leupeptin, and aprotinin) (Sigma). Whole cell lysates were prepared by passing the cell suspension through a 271/2-gauge needle 20 times and then centrifuging at 5000 x g for 5 min to remove debris. Whole cell lysates were incubated with butyl-Sepharose beads (Amersham Biosciences) (3:7 v/v ratio of beads to lysate) for 1 h at room temperature. Unbound and bound proteins were separated by centrifugation at 5000 x g for 5 min. Proteins were eluted from the resin in a series of 1/2 column volume washes. Equal amounts of each fraction were subjected to Western blot analysis.

Membrane Fractionation and Sodium Carbonate Extraction—Isolation of intracellular membranes by sodium carbonate treatment was as described (23). S2-DWnt-1 and S2-DFz2 cells were pelleted, resuspended in cold PBS and 0.05% CHAPS (2 x 105 cells/ml) containing 1x protease inhibitors mixture, and then lysed by passing the cell suspension 20 times through a 271/2-gauge needle. Lysates were centrifuged at 5000 x g for 5 min to remove debris, and then total membranes were isolated by centrifuging the lysate at 80,000 x g for 30 min at 4 °C. Membrane fractions were resuspended in 100 mM sodium carbonate at pH 11.0 for 30 min on ice followed by centrifugation at 80,000 x g for 1 h at 4 °C. Equal fractions of supernatant and pellet were subjected to 10% SDS-PAGE and analyzed by Western blotting.

Triton X-114 Phase Separation—5 x 106 cells were lysed in 1 ml of ice-cold Triton lysis buffer (200 µl of Tris-buffered saline-condensed Triton X-114 and 800 µl of Tris-buffered saline) and centrifuged for 10 min at 1000 x g at 4 °C, which was followed by gentle shaking at 4 °C for 1 h. Supernatant was incubated at 37 °C for 8 min and then centrifuged at 1000 x g at room temperature for 10 min. The aqueous phase and the detergent phase were separated, subjected to 10% SDS-PAGE, and analyzed by Western blotting.

Preparation of Whole Animal Extracts—hs-wg;porc- larva were generated by crossing porcPB16;FM7c females to hs-wg:TM6Tb males. Late third instar porcPB16;hs-wg animals were identified by scoring for non-Tubby, y-male larvae. Two genotypes were used for hs-wg control animals; they are hs-wg;FM7c (obtained from the cross described above) and hs-wg;TM6Tb. Individual larvae were heat-shocked for 1 h at 37 °C and then allowed to recover at 25 °C for 2 h. After heat shock and recovery, each animal was lysed individually. For butyl-Sepharose chromatography, each animal was lysed in 100 µl of binding buffer (100 mM NaCl, 10 mM Tris-Cl, pH 8.0, with 1x protease inhibitor mixture) by first homogenizing the animal with a pestle and then passing the extract 20 times through a 271/2-gauge syringe, which was followed by centrifugation at 5000 x g for 5 min to remove debris. Crude extracts were subjected to butyl-Sepharose chromatography.

For sodium carbonate extraction, crude protein extracts were obtained by homogenizing each larvae in cold PBS and 0.05% CHAPS (2 x 105 cells/ml) containing 1x protease inhibitors mixture as described above. After centrifuging at 5000 x g for 5 min to remove debris, the membrane fraction was isolated and subjected to sodium carbonate extraction as described above.

For Triton X-114 phase separation, each larva was lysed in 100 µl of ice-cold Triton lysis buffer by homogenization with a pestle, and then the lysate was passed through a 271/2-gauge needle 20 times. Protein extracts were subjected to Triton X-114 phase separation as described above.

Hydroxylamine Treatment of S2-DWnt-1 Whole Cell Extract—5 x 106 cells were collected and lysed in 500 µl of PBS with 1x protease inhibitors mixture. The lysates were mixed with 500 µl of 2 M Tris/HCl, pH 7.5, or 500 µl of 2 M hydroxylamine/HCl, pH 7.5, and incubated at 37 °C for 4 h. The samples were then subjected to butyl-Sepharose hydrophobic chromatography and Western blot analyses as described above.

Isolation of Lipid Raft Detergent-resistant Microdomains—Raft DRMs were prepared and isolated as described (24, 25). Briefly, cells were washed in PBS and then resuspended in cold TNET buffer (100 mM Tris, pH 7.5, 150 mM NaCl, 2 mM EGTA, 1% Triton X-100) with 1x protease inhibitor mixture. Cells were lysed by passing the suspension through a 271/2-gauge needle 20 times; lysates were centrifuged at 5000 x g for 5 min to remove debris, and the supernatant was diluted to 1:2 (v/v) with OptiPrepTM, a 60% (w/v) solution of iodixanol in water (Accurate Chemicals and Scientific Corp.) to reach a final concentration of 40% OptiPrep. Step gradients were formed in Beckman SW60 tubes by adding 1 ml of the 40% OptiPrep-cell suspension overlaid with 3.0 ml of 30% OptiPrep and 1.0 ml of 5% OptiPrep in TNET. Gradients were centrifuged at 40,000 rpm at 4 °C for 5 h. 0.5-ml fractions were collected (from the top). Equal amounts of each fraction were subjected 10% SDS-PAGE and analyzed by Western blotting. To isolate lipid rafts from larvae, each animal was lysed in 100 µl of TNET buffer and then was passed 20 times through a 271/2-gauge needle. Debris were removed by centrifuging the lysates at 5000 g for 5 min. The crude extract was mixed with 200 µl of 60% OptiPrep in TLS55 tubes (Beckman) and then overlaid with 900 µl of 30% OptiPrep, 300 µl of 5% OptiPrep. Gradients were centrifuged at 40,000 rpm at 4 °C for 5 h. 150-µl fractions were collected (from the top) and analyzed by Western blotting as described above.

Cholesterol/Sterol Depletion of S2 Cells Using Methyl-{beta}-cyclodextrin and Lovastatin—We examined the effects of lovastatin (gift from Merck and Co.) and methyl-{beta}-cyclodextrin at a variety of concentrations, checking both cell viability and cholesterol/ergosterol levels to identify the optimal conditions and drug concentrations. Confluent S2-DWnt-1 cells were incubated in lipid-free medium (Schneider's Drosophila medium with 5% charcoal-stripped fetal bovine serum and 2.5% penicillin/streptomycin) containing 0.5% methyl {beta}-cyclodextrin (Sigma) with ethanol or with 100, 200, and 500 µM lovastatin (Calbiochem) for 2-3 h at 25 °C and then heat-shocked at 37 °C for 1 h followed by a 2-h recovery at 25 °C. Cells were monitored hourly for viability. Loss on cell viability was <5% for cells treated with 100 and 200 µM lovastatin and 20-30% for cells cultured in 500 µM lovastatin. After treatment, the cells were collected and washed. Whole cell lysates were prepared and analyzed by fractionation over butyl-Sepharose as described above. Total lipids were extracted as described in Ref. 26. Neutral lipids were analyzed by multi-one-dimensional thin layer chromatography as described previously (27) using three sequential solvent systems: chloroform:methanol: acetic acid (90:10:0, v/v/v) and then hexane:diethyl ether:cetone (60: 40:5, v/v/v) followed by hexane:iethyl ether (97:3, v/v). The thin layer chromatography plates were sprayed with Premulin dye (Sigma), and the fractionated lipids were visualized using a PhosphorImager Storm 840 imaging system (Amersham Biosciences). Each lipid spot was compared with known standards and quantified using ImageQuant 2.0 software (Amersham Biosciences). After growth in 0.5% methyl-{beta}-cyclodextrin and 100 M lovastatin, S2 cells showed a 62% decrease in total cholesterol/ergosterol levels.

2-Bromopalmitate Treatment of S2 Cells—S2-DWnt-1 cells were grown to confluency and transferred into low fetal bovine serum medium (Schneider's Drosophila medium with 2.5% fetal bovine serum and 0.5% penicillin/streptomycin). Cells were incubated for 1-2 h at 25 °C with 2-bromopalmitate ranging from 0, 200, 400, and 800 µM in Me2SO. DWnt-1 expression was induced by heat shocking cells at 37 °C for 1 h and allowing them to recover at 25 °C for 2 h. Preparation of conditioned medium was as described in Reichsman et al. (4). Protein concentrations were determined using the BCA assay (Pierce).


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
A Posttranslational Modification in the ER Converts DWnt-1 Into a Membrane-anchored Protein—We started these studies by asking whether DWnt-1 displays hydrophobic properties similar to those described for murine Wnt-3a (5). The first set of experiments examined the hydrophobicity of Wnt-1 using standard hydrophobic chromatography techniques (Fig. 1a). Whole cell lysates were prepared from transgenic S2 cell lines expressing Wnt-1 under control of the inducible Hsp70 promoter (S2-DWnt-1). Extracts were solubilized in the presence of 0.025% CHAPS and then incubated with butyl-Sepharose. After incubation, the hydrophobic resin was washed, unbound proteins were collected, and bound proteins were eluted in a series of salt and detergent washes. All fractions were then analyzed by Western blotting. Hydrophilic proteins typically do not bind butyl-Sepharose; peripheral membrane proteins bind weakly and are usually eluted by agents that disrupt electrostatic and H-bond interactions. Integral membrane proteins bind tightly and are eluted only by detergents and organic solvents. The three panels in Fig. 1a show the elution profiles for DWnt-1, PCNA (a soluble hydrophilic nuclear protein), and DFz2 (a seven-pass transmembrane protein). As expected, PCNA did not bind butyl-Sepharose and was recovered in the flow-through (Fig. 1a, middle panel). DWnt-1 bound to the butyl-Sepharose beads, remained bound in subsequent low ionic strength washes, and was finally eluted by 1% SDS, a strongly ionic detergent (Fig. 1a, top panel). This type of chromatographic behavior is indicative of proteins that contain a strongly hydrophobic surface. In fact, the elution profile of DWnt-1 was identical to that of DFz2 (compare the top and bottom panels of Fig. 1a).



View larger version (33K):
[in this window]
[in a new window]
  		FIG. 1.
DWnt-1 displays the hydrophobic properties of a membrane-anchored protein. a, fractionation of DWnt-1 over the hydrophobic chromatography resin butyl-Sepharose. Included are Western blots showing the elution profiles for DWnt-1 (top panel); PCNA, a soluble nuclear protein (middle panel); and DFz2, a seven-pass transmembrane protein (bottom panel). DWnt-1 bound tightly to butylSepharose, and both did not elute until the SDS wash. PCNA did not bind and was found in the flow-through. The chromatographic profile of DFz2 was similar to that of DWnt-1. b, DWnt-1 segregates as a membrane-anchored protein after sodium carbonate extraction. Shown are Western blots of membrane and supernatant fractions after base extraction. DWnt-1 and DFz2 were detected in the membrane pellet, whereas PCNA was found in the supernatant (Supe). c, DWnt-1 partitions into the detergent phase after Triton X-114 phase separation. Western blots showing DWnt-1 and DFz2 partitioned into the Triton X-114 phase, whereas PCNA remained in the aqueous phase. St, starting materials.

 
These observations led us to hypothesize that DWnt-1 is partitioning as a membrane-anchored protein. We tested this hypothesis by asking whether DWnt-1 meets the standard experimental criteria for integral membrane proteins as defined by their behavior during sodium carbonate extraction and Triton X-114 phase separation (Fig. 1, b and c). S2 whole cell lysates were extracted with sodium carbonate, integral membrane proteins were separated from luminal and peripheral membrane proteins by centrifugation, and the fractions were analyzed by Western blotting (Fig. 1b). As expected, PCNA was found in the supernatant, whereas DWnt-1 and DFz2 remained with the membrane fraction. To be certain that DWnt-1 was partitioning into membranes and not simply precipitating at a high pH level, we also carried out Triton X-114 phase separation studies (Fig. 1c). Cells were lysed in the presence of Triton X-114, the insoluble material was discarded, and the aqueous and detergent phases were separated by centrifugation. Both phases were then examined by Western blotting. Fig. 1c shows that PCNA remained in the aqueous phase after Triton X-114 extraction, whereas DWnt-1 and DFz2 partitioned into the detergent phase. Thus in all three experiments, DWnt-1 displayed the characteristic properties of a membrane-anchored protein. This hydrophobicity is remarkably similar to that described previously for murine Wnt-3a (5), suggesting that it may be a feature common to many if not all Wnt ligands.

Two observations suggested that DWnt-1 is lipidated in the ER and that this posttranslational modification creates a membrane anchor. First, we found that DWnt-1 lost its hydrophobic properties after treatment with hydroxylamine-HCl (Fig. 2a). Hydroxylamine-HCl cleaves thioester and ester bonds, releasing fatty acyl groups from cysteine, serine, and threonine residues. Fig. 2a shows the butyl-Sepharose chromatographic profiles for DWnt-1 before and after hydroxylamine treatment. After treatment, the ligand no longer bound butyl-Sepharose, eluting instead in the flow-through fraction. Second, while carrying out a series of in vitro translation reactions with and without microsomes, we found that untranslocated DWnt-1 remained water-soluble, whereas DWnt-1 synthesized inside the ER partitioned as a membrane-anchored protein after sodium carbonate extraction (data not shown). Together, these results support the hypothesis that Wnt-1 hydrophobicity is a result of lipid modification, and the lipidation process occurs in the ER. Given previous work demonstrating that murine Wnt-3a is palmitoylated at amino acid 77, a conserved cysteine, we tested this idea directly.



View larger version (32K):
[in this window]
[in a new window]
  		FIG. 2.
Modification of DWnt-1 occurs by the addition of an ester- or thioester-linked acyl group. a, DWnt-1 loses its hydrophobic properties if thioester/ester-linked acyl groups are removed from the peptide backbone. This panel includes Western blots showing the butyl-Sepharose chromatographic profile of DWnt-1 after hydroxylamine treatment. b, The O-acyltransferase inhibitor 2-bromopalmitate (BrPal) blocks DWnt-1 acylation. This panel shows Western blots comparing the butyl-Sepharose chromatographic profiles of DWnt-1 isolated from S2-DWnt-1 cells grown in the presence and absence of 2-bromopalmitate. St, starting materials.

 
2-Bromopalmitate Inhibits DWnt-1 Lipidation—If DWnt-1 is modified by the addition of an ester- or thioester-linked lipid, it should be possible to block DWnt-1 lipidation by inhibiting acyltransferase activity. We tested this idea by expressing DWnt-1 in the presence and absence of 2-bromopalmitate and then assaying for DWnt-1 hydrophobicity. 2-Bromopalmitate blocks the transfer of palmitate from palmitoyl-CoA to cysteinyl thiols and is a general inhibitor of O-acyltransferase activities (28). The results are shown in Fig. 2b. DWnt-1 protein synthesized in the presence of 400 or 800 µm of 2-bromopalmitate showed a dramatic decrease in butyl-Sepharose binding and an apparent loss of hydrophobicity (Fig. 2b). These results argue that DWnt-1 is lipidated and that its hydrophobicity is most likely attributed to acyltransferase activity. We speculate that the lipid group is likely to be a palmitoyl adduct as has been reported for murine Wnt-3a (5). However, 2-bromopalmitate can also inhibit other enzymes associated with lipid metabolism (29). We have not been able to directly label DWnt-1 using a radiolabeled palmitate or palmitoyl-CoA precursor.2 Thus definitive confirmation of the lipid moiety may require direct physical measurements such as mass spectrometry analysis of fragmentation patterns.

Lipidation Targets DWnt-1 to Lipid Raft Microdomains—What is the functional significance of DWnt-1 lipidation? Because many palmitoylated proteins are associated with raft DRMs (6, 7), we wondered whether the lipid modification targets DWnt-1 to these specialized lipid microdomains. We investigated this possibility by isolating raft DRMs from S2-DWnt-1 cells and then assaying for the presence of raft DRM associated DWnt-1 (Fig. 3). Raft DRMs were isolated by treating S2-DWnt-1 cell lysates with cold 1% Triton X-100, layering the extracts on the bottom of discontinuous iodixanol (OptiPrep) density gradients, and subjecting the gradients to ultracentrifugation. The gradients were then fractionated and analyzed by immunoblotting with specific antibodies. The Western blots in Fig. 3A show the density profiles. We examined DWnt-1, syntaxin 1A (Syx1A), a raft-associated transmembrane protein, Drac1, an isoprenylated protein, and two soluble proteins, Hsp70 and PCNA. Because we used whole cell lysates rather than plasma membrane fractions, we were able to examine the total cellular distribution of each protein. Raft DRMs and raft-associated proteins are expected to float to the less dense fractions at the top of the gradient near the original 5 and 30% iodixanol gradients interface. We verified that we had successfully isolated raft DRMs by examining the density profile for Syx1A, (Fig. 3A, second panel). Syx1A separated into two pools, and most of the Syx1A was soluble and remained in fractions 8-10. However, some Syx1A was raft DRM-associated; this pool floated upward into fractions 2 and 3. The Syx1A profiles we obtained for Drosophila S2 cells were very similar to those reported previously for mammalian Syx1A (30). Hsp70 and PCNA, which are not raft DRM-associated, remained in the dense fractions at the bottom of the gradient (Fig. 3A, bottom two panels, fractions 8-10) after detergent solubilization and centrifugation. We also examined Drosophila Rac-1 (Drac-1). This small GTPase is a useful control because the protein is isoprenylated. Previous studies have shown that despite its lipid modification, isoprenylated Drac-1 does not segregate with lipid raft microdomains (24). Fig. 3A shows that as expected, Drac-1 remained in the soluble fractions and did not float upwards. Thus not all lipid modified proteins are able to partition into the detergent-insoluble fractions.



View larger version (39K):
[in this window]
[in a new window]
  		FIG. 3.
DWnt-1 is targeted to lipid raft detergent-insoluble microdomains in S2 cells. A, DWnt-1 partitions into lipid raft DRMs in S2 cells. Shown are Western blots of OptiPrep density gradients prepared from S2-DWnt-1 cell lysates. Lipid raft DRMs and DRM-associated proteins float up to the 5 and 30% OptiPrep gradient interface (fractions 2 and 3). Both DWnt-1 and syntaxin 1A (Syx1A) (24) partitioned into two pools. The raft DRM-associated DWnt-1 and Syx1A floated to the less dense fractions near the top of the gradient (top two panels, fractions 2 and 3). The detergent-soluble DWnt-1 and Syx1A pools remained at the bottom of the gradient. Drac-1, Hsp70, and PCNA also remained in the dense fractions at the bottom of the gradient (bottom two panels, fractions 8-10). B and C, depleting cholesterol/sterol pools did not inhibit DWnt-1 hydrophobicity. S2-DWnt-1 cells were cultured in the presence and absence of lovastatin and 0.5% methyl-{beta}-cyclodextrin. DWnt-1 hydrophobicity was assayed by butylSepharose chromatography (B) and sodium carbonate extraction (C). D, cholesterol/sterol depletion blocks the assembly of raft DRMS and disrupts DWnt-1 targeting. Shown are Western blots of the OptiPrep density gradients prepared from S2-DWnt-1 cells cultured in the presence and absence of lovastatin and 0.5% methyl-{beta}-cyclodextrin. As the concentration of the cholesterol depleting drugs increased, the amount of raft DRM-associated DWnt-1 and Syx1A decreased. St, starting materials.

 
DWnt-1 behaved very much like Syx1A. Most DWnt-1 remained in the soluble protein fractions; however, some floated to the less dense raft DRMs fractions (Fig. 3A, top panel). In other words, a portion of the total intracellular DWnt-1 was associated with raft DRMs. The fact that most DWnt-1 was detergent-soluble is consistent with earlier studies showing that only a small fraction of DWnt-1 is actually secreted by S2 cells (4). Few cell lines are able to secrete Wnt ligands, and in those that do secretion is very inefficient (31). Assembly of small raft DRMs typically begins in the trans Golgi with larger microdomains forming at the plasma membrane (8). We speculate that most of the lipidated DWnt-1 remains in the ER and/or Golgi compartments.

To be certain that DWnt-1 floated to the less dense fractions only when associated with raft DRMs and not simply because of the posttranslational modification, we repeated these experiments under conditions that prohibit raft DRM assembly. Cholesterol and similar sterols are major constituents of lipid rafts. Drugs such as methyl-{beta}-cyclodextrin and lovastatin deplete cholesterol levels and prevent raft DRM formation (32). We cultured S2-DWnt-1 cells in the presence of 0.5% {beta}-cyclodextrin plus lovastatin, induced DWnt-1 expression, and then assayed for changes in DWnt-1 trafficking. Total neutral lipids were extracted from the treated and non-treated cells and then analyzed by thin layer chromatography to confirm that methyl-{beta}-cyclodextrin and lovastatin treatment depleted the intracellular cholesterol/sterol pools. We found that S2 cells are unusually refractive to treatment with a variety of drugs. In this case, we examined the effects of lovastatin and cyclodextrin at a variety of concentrations, checking both cell viability and cholesterol/ergosterol levels to identify the optimal conditions. When grown in the presence of lipid-free medium treated with 0.5% cyclodextrin and lovastatin for 5-6 h, S2 cells showed a 62% decrease in cholesterol/ergosterol levels. Cells were also monitored for viability. At 100 and 200 µM lovastatin >95% of the cells remained viable, and at 500 µM lovastatin 70-80% of the cells remained viable during the culture period.

Growth in {beta}-cyclodextrin and lovastatin did not affect DWnt-1 hydrophobicity. Even when synthesized in the presence of 200 µM lovastatin, DWnt-1 retained its affinity for butyl-Sepharose binding (Fig. 3B) and continued to partition as a membrane-anchored protein after sodium carbonate extraction (Fig. 3C). We interpret these results to mean that lowering the intracellular cholesterol/sterol levels did not disrupt DWnt-1 acylation. {beta}-Cyclodextrin and lovastatin treatment did inhibit the assembly of raft DRMs in the S2 cells. After lysing treated and untreated cells with cold Triton X-100, we carried out density gradient centrifugations and assayed for raft DRMs as described above. Western blots of the iodixanol gradients are shown in Fig. 3D. As predicted, cholesterol/sterol depletion blocked the formation of Syx1A-associated raft DRMs. When cells were grown in 100 µM lovastatin, we observed a significant decrease in the amount of raft DRM-associated Syx1A. At 200 µM lovastatin, we were unable to detect any Syx1A in the less dense fractions. Cholesterol/sterol depletion also blocked the partition of DWnt-1 into lipid rafts. As the concentration of lovastatin increased, the amount of DWnt-1 floating in the less dense fractions decreased. At 200 µM lovastatin, essentially all DWnt-1 remained in the soluble fractions (fractions 8-10). Together, the experiments shown in Fig. 3 confirm that DWnt-1 is selectively partitioned into raft DRMs.

2-Bromopalmitate Inhibits DWnt-1 Association with Raft DRMs—Palmitate and other long chain saturated fatty acids often partition with cholesterol and glycosphingolipids (7, 33). This led us to wonder whether the lipid group attached to DWnt-1 group is responsible for partitioning the ligand into lipid raft DRMs. We investigated this possibility by asking whether 2-bromopalmitate treatment can inhibit the assembly of DWnt-1-associated raft DRMs. DWnt-1 expression was induced in the presence and absence of 2-bromopalmitate, the cells were collected, treated with cold Triton X-100, and raft DRMs were isolated by discontinuous density gradient centrifugation. Western blots of the gradient fractions are shown in Fig. 4. Again Syx1A was used as a positive control for raft-targeted proteins. Because Syx1A is not palmitoylated, inhibiting O-acyltransferase activity should not affect the association of Syx1A with raft DRM. The blots in Fig. 4 confirmed this. Even when the cells were grown in the presence of 800 µM 2-bromopalmitate, Syx1A continued to partition into raft DRMs. The results obtained for DWnt-1 were quite different in that 2-bromopalmitate inhibited DWnt-1 incorporation into the lipid rafts, and the inhibiting effect appeared to be concentration dependent. When cells were cultured in 200 µM 2-bromopalmitate, the amount of DWnt-1 that floated to the raft fractions was decreased. The pool of raft DRM-associated DWnt-1 continued to drop at 400 and 800 µM inhibitor. These data indicate that O-acyltransferase activity is essential for DWnt-1 targeting to lipid raft DRMs. Together with the findings described above, the results argue that DWnt-1 acylation is a requisite step for lateral targeting of the ligand to specialized detergent-resistant regions within the membrane.



View larger version (44K):
[in this window]
[in a new window]
  		FIG. 4.
Lipidation is required for DWnt-1 targeting to lipid raft DRMs. The figure shows Western blots of density gradients obtained from S2-DWnt-1 cells grown in the presence and absence of 2-bromoplamitate. DWnt-1 synthesized in the presence of the acyltransferase inhibitor did not associate with lipid raft DRMs (middle three panels). Note that 2-bromoplamitate (Br-Pal) did not interfere with the assembly of Syx1A-raft DRM particles, even at 800 µM 2-bromoplamitate (bottom panel).

 
Porcupine, a Putative O-Acyltransferase, Is Required for DWnt-1 Hydrophobicity and for Raft Targeting—Next, we turned to the question of whether Porcupine is essential for DWnt-1 acylation and/or raft trafficking. Rather than use S2 cells, which express porcupine constitutively (17), we decided to follow DWnt-1 expression in whole animals, using both control and porcupine- (porc-) mutant animals. Because DWnt-1 is expressed at very low levels in wild-type animals and cannot be detected by Western blotting, we used two transgenic strains for these experiments. The control animals we used were male hs-wg;porc+ late third instar larvae; these animals express high levels of DWnt-1 in a wild-type background. The porc- animals we used were male hs-wg;porcPB16 late third instar larvae; these animals express high levels of DWnt-1 but lack zygotic Porcupine activity.

Whole animal extracts were prepared, and protein hydrophobicity was measured by butyl-Sepharose chromatography, sodium carbonate extraction, and Triton X-100 phase separation. The results are shown in Fig. 5, A-C. DWnt-1 isolated from control animals displayed the same hydrophobic chromatography profile as DWnt-1 isolated from transgenic S2 cells (compare Fig. 5A with Fig. 1a). In contrast, DWnt-1 isolated from porc- animals did not bind butyl-Sepharose and was recovered in the flow-through. The change in DWnt-1 hydrophobicity was confirmed by sodium carbonate extractions and Triton X-114 phase separations (Fig. 5, B and C). DWnt-1 obtained from control animals partitioned with intrinsic membrane proteins during both assays. However, DWnt-1 obtained from porc- animals, i.e. DWnt-1 synthesized in the absence of Porcupine, fractionated with soluble hydrophilic proteins. When porc- lysates were treated with sodium carbonate, DWnt-1 was released into the supernatant (Fig. 5B). Further quantification analysis by ImageJ showed that in porc- animals, only 6.69% of DWnt-1 protein was membrane-associated versus 80.76% of DWnt-1 in wild type animals. Similarly, when porc- lysates were extracted with Triton X-114, DWnt-1 partitioned into the soluble aqueous phase (Fig. 5C). We conclude that porcupine is required for DWnt-1 to exhibit its normal hydrophobicity and membrane association.



View larger version (34K):
[in this window]
[in a new window]
  		FIG. 5.
Porcupine is required for DWnt-1 lipidation and targeting to lipid raft DRMs. The membrane binding properties of DWnt-1 depend on Porcupine activity. Whole animal lysates were prepared from hs-wg control and hs-wg porc- animals as described under "Materials and Methods," and DWnt-1 hydrophobicity was analyzed. A, butylSepharose chromatography profiles; B, sodium carbonate extractions; C, Triton X-100 phase separations. D, DWnt-1 synthesized in the absence of functional Porcupine does not associate with lipid raft DRMs. Western blots of OptiPrep gradients prepared from control (top four panels) and porc- animals (bottom two panels). Syx1A, Drac-1, and Hsp70 are shown as controls. Supe, supernatant; St, starting materials.

 
We also examined DWnt-1 targeting to raft DRMs in the presence and absence of Porcupine. We isolated individual control and porc- larvae, solubilized the tissues with cold Triton X-100, and isolated raft DRMs by discontinuous density gradient ultracentrifugation. Western blots of the gradient fractions are shown in Fig. 5D. The top four panels show the profiles obtained for the control animals. DWnt-1 and Syx1A were present in both Triton X-100-soluble and detergent-insoluble fractions, whereas Drac1 and Hsp70 remained in the dense fractions at the bottom of the tube. These results demonstrate for the first time that DWnt-1 is targeted to raft DRMs in larval tissues as well as cultured S2 cells.

When we analyzed DWnt-1 obtained from porc- animals, we obtained very different results. The entire pool of DWnt-1 synthesized in porc- animals remained in the detergent-soluble fractions (Fig. 5D). We did not find any DWnt-1 floating in the less dense raft DRMs fractions. However, the association of Syx1A was not disrupted in the porc- animals, indicating that porc- animals are able to assemble lipid raft microdomains and that other proteins can be partitioned into raft DRMs in the absence of Porcupine. We conclude that Porcupine activity is essential for the lateral targeting of DWnt-1 to raft DRMs in vivo. These findings lead us to hypothesize that DWnt-1 targeting to raft DRMs may be a requisite step for normal DWnt-1 secretion.

In summary, we have found that Porcupine is required for DWnt-1 hydrophobicity and raft targeting, and previous studies have shown that Porcupine is also required for DWnt-1 secretion. Can all Porcupine-dependent defects in DWnt-1 signaling be attributed to the loss of DWnt-1 acylation? One way to address this question is to ask whether all of the Porcupine defects can be phenocopied by inhibiting O-acyltransferase activity. We have already shown that 2-bromopalmitate treatment of S2 cells is sufficient to inhibit DWnt-1 hydrophobicity and raft targeting. In a last set of experiments, we asked whether the inhibitor also blocks DWnt-1 secretion.

S2-DWnt-1 cells were washed, heat-shocked, and cultured for 3 h with or without 2-bromopalmitate. Both conditioned media and cells were collected and analyzed by Western blotting. The results are shown in Fig. 6. Whole cell lysates prepared from untreated and treated cells contained equivalent amounts of DWnt-1 and Hsp-70 (Fig. 6), indicating that 2-bromopalmitate treatment did not inhibit gene expression during the 3-h recovery. Likewise, the two conditioned media samples contained equivalent amounts of total extracellular protein (1.61 µg/µl in the untreated sample versus 1.65 µg/µl in the treated sample) demonstrating that 2-bromopalmitate did not act as a general inhibitor of protein secretion. However, secreted DWnt-1 was present only in the untreated conditioned medium (compare the two top panels in Fig. 6). When DWnt-1 was synthesized in the presence of the O-acyltransferase inhibitor, we were unable to detect any extracellular ligand. Either DWnt-1 was not secreted or it was rapidly degraded. In either case, the absence of detectable extracellular DWnt-1 correlates with immunocytochemical studies showing the absence of extracellular DWnt-1 staining in porc- animals (21, 36). Together, these experiments show that 2-bromopalmitate treatment was able to phenocopy each of the known Porcupine-dependent defects, suggesting again that maturation and secretion of active DWnt-1 ligand requires an acyltransferase activity encoded by porcupine. We have also found that blocking raft DRM formation by cholesterol/sterol depletion also blocked the secretion of DWnt-1 but not that of Hsp70 (data not shown). Although we cannot rule out the possibility that blocking sterol synthesis may have a general inhibitory effect on protein secretory pathways in the cells, these observations support the idea that appropriate sorting of DWnt-1 (into lipid rafts) is critical for its secretion.



View larger version (55K):
[in this window]
[in a new window]
  		FIG. 6.
2-Bromopalmitate blocks the secretion of DWnt-1. Western blots comparing DWnt-1 synthesis and secretion when S2-DWnt-1 cells were grown in the presence and absence of 2-bromopalmitate (Br-Pal) are shown. Whole cell lysates (WCL) prepared from treated and untreated cells contained equivalent amounts of DWnt-1. Conditioned medium (CM) from treated and untreated cells contained equivalent amounts of total protein, and the two conditioned media samples contained equivalent amounts of total extracellular protein (1.65 and 1.61 µg/µl, respectively). Secreted DWnt-1 was detected only in the conditioned medium samples prepared from untreated cells. Hsp70 was used as a loading control to confirm that equal amounts of protein were loaded and transferred to the Western blot.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
Nusse and co-workers (5) first demonstrated that murine Wnt-3a is palmitoylated at a conserved cysteine residue and proposed that palmitoyl modifications may be a common feature among Wnt ligands. Our studies provide evidence that Drosophila Wnt-1 is also lipidated. We have shown that newly synthesized DWnt-1 undergoes a posttranslational modification in which a thioester-linked lipid group is attached to the peptide backbone. Attachment of the lipid affects subsequent DWnt-1 trafficking and secretion in that the lipidated ligand partitions as a membrane-anchored protein and is targeted to lipid raft DRMs before secretion. This lipid modification requires Porcupine, a putative ER membrane-bound O-acyltransferase and can be inhibited by 2-bromopalmitate, a competitive inhibitor of palmitoyl acyltransferases.

Lipidation is likely to play a significant role in the maturation and secretion of many if not all Wnt ligands. Recent studies with mammalian cells have shown that Porcupine is required for secretion of murine Wnt-1, -3A, -4, -6 and -7B (18). Interestingly, whereas vertebrates have a single porc gene, four different porc transcripts are generated via alternative mRNA splicing (18, 19). Sequence analyses suggest that each transcript encodes a putative acyltransferase; however, it is possible that the isoforms exhibit different lipid and protein substrate specificities (35).

How important is Wnt lipidation? What is its function? Here we have focused on the upstream events that control production and proper secretion of active DWnt-1 ligand. Animals lacking porcupine activity synthesize DWnt-1, but the unmodified protein does not associate with membranes and is not secreted. Both defects can be phenocopied in S2 cells by the addition of 2-bromopalmitate. These findings are consistent with a growing body of literature demonstrating that lipidation is often used to regulate protein trafficking. Cooperative lipidlipid interactions between the lipid moiety and membrane lipids can help target the modified protein to specific vesicles and lipid microdomains. Palmitate groups, which partition with cholesterol and sphingolipids, are important determinants for apical sorting and targeting to raft DRMs (8). We have found that the membrane-associated DWnt-1 is partitioned into lipid raft DRMs. Lipidation appears to be requisite for raft targeting as the association of DWnt-1 with raft DRM particles is dependent on porcupine activity and can be blocked by treating cells with 2-bromopalmitate. Our experiments do not rule out the possibility that DWnt-1 undergoes multiple lipid modifications. Additional palmitate groups or other lipid moieties may be added in subsequent steps. Many proteins require at least two saturated acyl chains for raft targeting (36).

Based on our results, we propose a pathway for DWnt-1 maturation and trafficking to the cell surface as follows. DWnt-1 undergoes at least two types of modifications in the ER, which are a Porcupine-dependent fatty acylation and the addition of two Asn-linked high mannose sugars. After glycosylation and lipidation, the protein is transported from the ER to the Golgi where it is partitioned into polarized vesicles and then transported to cholesterol/sphingolipid-rich raft DRMs at the cell surface. In porc- mutant animals, DWnt-1 is synthesized and glycosylated, but in the absence of functional Porcupine the ligand is not lipidated. Lacking the appropriate fatty acid sorting signal DWnt-1 does not partition with cholesterol/sphingolipid-rich microdomains and is not transported to the cell surface. Immunocytochemical staining of DWnt-1 expression in porcupine mutant animals suggests that the immature ligand accumulates in the ER and/or early Golgi vesicles (34). Similar results have been reported for apolipoprotein B. Palmitoylation of apolipoprotein B concentrates the protein in specialized compartments within the ER, stimulates ER to Golgi transport, and promotes secretion (37).

In summary, our data argue that DWnt-1 is not secreted through the classical constitutive pathway. Instead, DWnt-1 undergoes a Porcupine-dependent lipidation; the lipid group functions as a sorting signal, targeting the ligand to polarized vesicles that transport DWnt-1 to unique sites at the cell surface. This pathway is not unlike apical secretion in mammalian cells, where secretory proteins partition with cholesterol-sphingolipid rich microdomains within the trans Golgi network and are then transported directly to the plasma membrane (8).

After reaching the cell surface, how is DWnt-1 secreted? Numerous immunocytochemical studies indicate that extracellular DWnt-1 is concentrated in large punctate particles (38, 39). Given that extracellular Wnts are lipid modified (Ref. 5),2 secretion is likely to require additional processing steps in which the ligand is either packaged into extracellular secretory vesicles or assembled into lipoprotein aggregates that are then released from the cell surface. The first model is compatible with work by Greco et al. (40) suggesting that extracellular DWnt-1 is transported via argosomes, extracellular vesicles that travel from cell to cell. We note that argosome budding and release may take place near lipid raft DRMs (40, 41). If so, then Porcupine-dependent acylation and subsequent raft targeting may ensure that DWnt-1 is concentrated at the site of argosome budding, perhaps promoting the subsequent packaging of DWnt-1 into argosome vesicles.

Our data, considered with other recent studies on Wnt and Hh signaling, suggest that Wnt and Hh ligands may utilize similar mechanisms for transport, secretion, and extracellular movement (14). Hh contains both palmitoyl and cholesterol groups; these lipid modifications target Hh to lipid raft DRMs at the surface (13, 24). Extracellular Hh-Np is also found in large particles. The assembly of these Hh-Np aggregates depends on cholesterol and dispatched, and movement of the aggregates from the signaling to the receiving cells is dependent on heparan sulfate proteoglycans (13, 42-44). In summary, lipid modifications provide important signals for targeting morphogens to specific membrane compartments, and they are likely to participate in the packaging, secretion, and perhaps delivery of the morphogen to the responding cells.


   FOOTNOTES
 
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} Present address: Dept. of Pharmacology, Loyola University Medical Center, 2160 S. 1st Ave., Maywood, IL 60153. Back

§ To whom correspondence should be addressed. Tel.: 413-545-4031; Fax: 413-577-4031; E-mail: susanc{at}biochem.umass.edu.

1 The abbreviations used are: DRM, detergent-resistant microdomain; ER, endoplasmic reticulum; PCNA, proliferating cell nuclear antigen; PBS, phosphate-buffered saline; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; DFz2, DFrizzled2; Syx1A, syntaxin 1A; porc-, porcupine-; Hh, hedgehog; Drac-1, Drosophila Rac-1. Back

2 L. Zhai, D. Chaturvedi, and S. Cumberledge, unpublished results. Back



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Martinez Arias, A. (2003) Nat. Rev. Mol. Cell. Biol. 4, 321-325[CrossRef][Medline] [Order article via Infotrieve]
  2. Huelsken, J., and Behrens, J. (2002) J. Cell Sci. 115, 3977-3978[Free Full Text]
  3. Moon, R. T., Bowerman, B., Boutros, M., and Perrimon, N. (2002) Science 296, 1644-1646[Abstract/Free Full Text]
  4. Reichsman, F., Smith, L., and Cumberledge, S. (1996) J. Cell Biol. 135, 819-827[Abstract/Free Full Text]
  5. Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., III, and Nusse, R. (2003) Nature 423, 448-452[CrossRef][Medline] [Order article via Infotrieve]
  6. Linder, M. E., and Deschenes, R. J. (2003) Biochemistry 42, 4311-4320[CrossRef][Medline] [Order article via Infotrieve]
  7. Patterson, S. I. (2002). Biol. Res. 35, 139-150[Medline] [Order article via Infotrieve]
  8. Ikonen, E., and Simons, K. (1998) Semin. Cell Dev. Biol. 9, 503-509[CrossRef][Medline] [Order article via Infotrieve]
  9. Simons, K., and Ikonen, E. (1997) Nature 387, 569-572[CrossRef][Medline] [Order article via Infotrieve]
  10. Qanbar, R., and Bouvier, M. (2003) Pharmacol. Ther. 97, 1-33[CrossRef][Medline] [Order article via Infotrieve]
  11. Pepinsky, R. B., Zeng, C., Wen, D., Rayhorn, P., Baker, D. P., Williams, K. P., Bixler, S. A., Ambrose, C. M., Garber, E. A., Miatkowski, K., Taylor, F. R., Wang, E. A., and Galdes, A. (1998) J. Biol. Chem. 273, 14037-14045[Abstract/Free Full Text]
  12. Chamoun, Z., Mann, R. K., Nellen, D., von Kessler, D. P., Bellotto, M., Beachy, P. A., and Basler, K. (2001) Science 293, 2080-2084[Abstract/Free Full Text]
  13. Gallet, A., Rodriguez, R., Ruel, L., and Therond, P. P. (2003) Dev. Cell 4, 191-204[CrossRef][Medline] [Order article via Infotrieve]
  14. Nusse, R. (2003) Development (Camb.) 130, 5297-5305[Abstract/Free Full Text]
  15. Jeong, J., and McMahon, A. P. (2002) J. Clin. Investig. 110, 591-596[CrossRef][Medline] [Order article via Infotrieve]
  16. Hofmann, K. (2000) Trends Biochem. Sci. 25, 111-112[CrossRef][Medline] [Order article via Infotrieve]
  17. Kadowaki, T., Wilder, E., Klingensmith, J., Zachary, K., and Perrimon, N. (1996) Genes Dev. 10, 3116-3128[Abstract/Free Full Text]
  18. Tanaka, K., Okabayashi, K., Asashima, M., Perrimon, N., and Kadowaki, T. (2000) Eur. J. Biochem. 267, 4300-4311[Medline] [Order article via Infotrieve]
  19. Caricasole, A., Ferraro, T., Rimland, J. M., and Terstappen, G. C. (2002) Gene (Amst.) 288, 147-157[CrossRef][Medline] [Order article via Infotrieve]
  20. Thorpe, C. J., Schlesinger, A., Carter, J. C., and Bowerman. B. (1997) Cell 90, 695-705[CrossRef][Medline] [Order article via Infotrieve]
  21. van den Heuvel, M., Harryman-Samos, C., Klingensmith, J., Perrimon, N., and Nusse, R. (1993) EMBO J. 12, 5293-5302[Medline] [Order article via Infotrieve]
  22. Tanaka, K., Kitagawa, Y., and Kadowaki, T. (2002) J. Biol. Chem. 277, 12816-12823[Abstract/Free Full Text]
  23. Fujiki, Y., Hubbard, A. L., Fowler, S., and Lazarow, P. B. (1983) J. Cell. Biol. 93, 97-102
  24. Rietveld, A., Neutz, S., Simon, K., and Eaton, S. (1999) J. Biol. Chem. 274, 12049-12054[Abstract/Free Full Text]
  25. Waheed, A., and Jones, T. (2002) J. Biol. Chem. 277, 32409-32412[Abstract/Free Full Text]
  26. Jones, H. E., Harwood, J. L., Bowen, I. D., and Griffiths, G. (1992) Lipids 27, 984-987[Medline] [Order article via Infotrieve]
  27. White, T., Bursten, S., Federighti, D., Lewis, R. A., and Nudelman, E. (1998) Anal. Biochem. 258, 109-117[CrossRef][Medline] [Order article via Infotrieve]
  28. Webb, Y., Hermida-Matsumoto, L., and Resh, M. D. (2000) J. Biol. Chem. 275, 261-270[Abstract/Free Full Text]
  29. Coleman, R. A., Rao, P., Fogelsong, R. J., and Bardes, E. S. (1992) Biochim. Biophys. Acta 1125, 203-209[Medline] [Order article via Infotrieve]
  30. Chamberlain, L., Burgoyne, R., and Gould, G. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 5619-5624[Abstract/Free Full Text]
  31. Papkoff, J. (1989) Mol. Cell. Biol. 9, 3377-3384[Abstract/Free Full Text]
  32. Hansen, G. H., Niels-Christiansen, L. L., Thorsen, E., Immerdal, L., and Danielsen, E. M. (2000) J. Biol. Chem. 275, 5136-5142[Abstract/Free Full Text]
  33. Resh, M. D. (1999) Biochim. Biophys. Acta 1451, 1-16[Medline] [Order article via Infotrieve]
  34. Packard, M., Koo, E. S., Gorczyca, M., Sharpe, J., Cumberledge, S., and Budnik, V. (2002) Cell 111, 319-330[CrossRef][Medline] [Order article via Infotrieve]
  35. Tanaka, K., Kitagawa, Y., and Kadowaki, T. (2003) Cell Biol. Int. 27, 549-557[CrossRef][Medline] [Order article via Infotrieve]
  36. van Meer, G. (2002) Science 296, 855-856[Abstract/Free Full Text]
  37. Vilas, G. L., and Berthiaume, L. G. (2004) Biochem. J. 377, 121-130[CrossRef][Medline] [Order article via Infotrieve]
  38. van den Heuvel, M., Nusse, R., Johnston, P., and Lawrence, P. A. (1989) Cell 59, 739-749[CrossRef][Medline] [Order article via Infotrieve]
  39. Gonzalez, F., Swales, L., Bejsovec, A., Skaer, H., and Martinez Arias, A. (1991) Mech. Dev. 35, 43-54[CrossRef][Medline] [Order article via Infotrieve]
  40. Greco, V., Hannus, M., and Eaton, S. (2001) Cell 106, 633-645[CrossRef][Medline] [Order article via Infotrieve]
  41. Vincent, J. P., and Magee, T. (2002) Trends Cell Biol. 12, 57-60[CrossRef][Medline] [Order article via Infotrieve]
  42. Bellaiche, Y., The, I., and Perrimon, N. (1998) Nature 394, 85-88[CrossRef][Medline] [Order article via Infotrieve]
  43. The, I., Bellaiche, Y., and Perrimon, N. (1999) Mol. Cell 4, 633-639[CrossRef][Medline] [Order article via Infotrieve]
  44. Zeng, X., Goetz, J. A., Suber, L. M., Scott, W. J., Jr., Schreiner, C. M., and Robbins, D. J. (2001) Nature 411, 716-720[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. DeMorrow, H. Francis, E. Gaudio, J. Venter, A. Franchitto, S. Kopriva, P. Onori, R. Mancinelli, G. Frampton, M. Coufal, et al.
The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway
Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1150 - G1158.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
R. Nusse, C. Fuerer, W. Ching, K. Harnish, C. Logan, A. Zeng, D. ten Berge, and Y. Kalani
Wnt Signaling and Stem Cell Control
Cold Spring Harb Symp Quant Biol, November 26, 2008; (2008) sqb.2008.73.035v2.
[Abstract] [PDF]

Home page
 J. Lipid Res.Home page
C.-L. E. Yen, S. J. Stone, S. Koliwad, C. Harris, and R. V. Farese Jr.
Thematic Review Series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis
J. Lipid Res., November 1, 2008; 49(11): 2283 - 2301.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
S. Noisakran, T. Dechtawewat, P. Avirutnan, T. Kinoshita, U. Siripanyaphinyo, C. Puttikhunt, W. Kasinrerk, P. Malasit, and N. Sittisombut
Association of dengue virus NS1 protein with lipid rafts
J. Gen. Virol., October 1, 2008; 89(10): 2492 - 2500.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Ching, H. C. Hang, and R. Nusse
Lipid-independent Secretion of a Drosophila Wnt Protein
J. Biol. Chem., June 20, 2008; 283(25): 17092 - 17098.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. Hebbar, E. Lee, M. Manna, S. Steinert, G. S. Kumar, M. Wenk, T. Wohland, and R. Kraut
A fluorescent sphingolipid binding domain peptide probe interacts with sphingolipids and cholesterol-dependent raft domains
J. Lipid Res., May 1, 2008; 49(5): 1077 - 1089.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
L. M. Galli, T. L. Barnes, S. S. Secrest, T. Kadowaki, and L. W. Burrus
Porcupine-mediated lipid-modification regulates the activity and distribution of Wnt proteins in the chick neural tube
Development, September 15, 2007; 134(18): 3339 - 3348.
[Abstract] [Full Text] [PDF]

Home page
 GENES CELLSHome page
H. Komekado, H. Yamamoto, T. Chiba, and A. Kikuchi
Glycosylation and palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a
Genes Cells, April 1, 2007; 12(4): 521 - 534.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
D. Coudreuse and H. C. Korswagen
The making of Wnt: new insights into Wnt maturation, sorting and secretion
Development, January 1, 2007; 134(1): 3 - 12.
[Full Text] [PDF]

Home page
 DevelopmentHome page
R. M. Goodman, S. Thombre, Z. Firtina, D. Gray, D. Betts, J. Roebuck, E. P. Spana, and E. M. Selva
Sprinter: a novel transmembrane protein required for Wg secretion and signaling
Development, December 15, 2006; 133(24): 4901 - 4911.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
M. D. Resh
Palmitoylation of Ligands, Receptors, and Intracellular Signaling Molecules
Sci. Signal., October 31, 2006; 2006(359): re14 - re14.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
X. He and J. D. Axelrod
A WNTer wonderland in Snowbird.
Development, July 1, 2006; 133(14): 2597 - 2603.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
D. A. Mitchell, A. Vasudevan, M. E. Linder, and R. J. Deschenes
Thematic review series: Lipid Posttranslational Modifications. Protein palmitoylation by a family of DHHC protein S-acyltransferases
J. Lipid Res., June 1, 2006; 47(6): 1118 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
B. C. Prasad and S. G. Clark
Wnt signaling establishes anteroposterior neuronal polarity and requires retromer in C. elegans
Development, May 1, 2006; 133(9): 1757 - 1766.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. T. Struewing, A. Toborek, and C. D. Mao
Mitochondrial and Nuclear Forms of Wnt13 Are Generated via Alternative Promoters, Alternative RNA Splicing, and Alternative Translation Start Sites
J. Biol. Chem., March 17, 2006; 281(11): 7282 - 7293.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
E. Marois, A. Mahmoud, and S. Eaton
The endocytic pathway and formation of the Wingless morphogen gradient
Development, January 15, 2006; 133(2): 307 - 317.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
D. Avisar, M. Segal, B. Sneh, and A. Zilberstein
Cell-cycle-dependent resistance to Bacillus thuringiensis Cry1C toxin in Sf9 cells
J. Cell Sci., July 15, 2005; 118(14): 3163 - 3171.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Xin, R. E. Mains, and B. A. Eipper
Monooxygenase X, a Member of the Copper-dependent Monooxygenase Family Localized to the Endoplasmic Reticulum
J. Biol. Chem., November 12, 2004; 279(46): 48159 - 48167.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/32/33220    most recent
M403407200v2
M403407200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhai, L.
Right arrow Articles by Cumberledge, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhai, L.
Right arrow Articles by Cumberledge, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement